Most Recent

image: Fecal Transplant Pill Fails Trial

Fecal Transplant Pill Fails Trial

By | August 1, 2016

Seres Therapeutics’s microbiome-targeting therapy for recurrent Clostridium difficile infection fails a Phase 2 clinical trial.

2 Comments

From sequencing bacteriophages to synthesizing bacterial genomes to defining a minimal genome

0 Comments

image: Cullen Buie Parses Pathogens With Passion

Cullen Buie Parses Pathogens With Passion

By | August 1, 2016

Associate Professor, Department of Mechanical Engineering, MIT. Age: 34

1 Comment

By ditching traditional agar-based media, two biochemists captured iconic images of Myxococcus in 1982.

0 Comments

image: Riboswitch Screen

Riboswitch Screen

By | August 1, 2016

A newly developed method detects regulators of bacterial transcription called riboswitches.

0 Comments

image: Wanted: Transcriptional Regulators

Wanted: Transcriptional Regulators

By | August 1, 2016

Researchers have designed a screen to find unique molecules, called riboswitches, that determine whether transcription will proceed.

0 Comments

image: Classic Example of Symbiosis Revised

Classic Example of Symbiosis Revised

By | July 25, 2016

The partnering of an alga and a fungus to make lichen may be only two-thirds of the equation.

0 Comments

image: CRISPR Therapy to Enter Trials

CRISPR Therapy to Enter Trials

By | July 25, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

0 Comments

image: Arming Synthetic Bacteria Against Cancer

Arming Synthetic Bacteria Against Cancer

By | July 20, 2016

Researchers engineer bacteria that deliver an anti-tumor toxin in mice before self-destructing. 

0 Comments

image: Distinguishing Circulating Tumor from Normal Cell-Free DNA

Distinguishing Circulating Tumor from Normal Cell-Free DNA

By | July 19, 2016

Fragments of circulating DNA from tumors are around 20 to 30 base pairs shorter than those from healthy cells, researchers report.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech